World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
8238
World Ranking
4262
National Ranking
203

Overview

Jean Lang is affiliated with Sanofi in France, focusing on research within the field of medicine. Their work spans several interrelated subfields including public health, environmental and occupational health, epidemiology, rheumatology, and health. The primary topics of their research revolve around mosquito-borne diseases and control, herpesvirus infections and treatments, systemic lupus erythematosus research, and vaccine coverage and hesitancy.

Jean Lang has contributed to multiple publications, prominently appearing in the journal Value in Health, with three papers published there, and one paper available through UNC Libraries. Their recent body of work includes the following papers:

  • Stability of Yellow Fever Virus under Recombinatory Pressure as Compared with Chikungunya Virus, 2020, UNC Libraries
  • EE50 Estimating the Clinical and Economic Outcomes of Universal Varicella and Herpes Zoster Vaccination in Belgium Using a Dynamic Transmission Model With Dynamic Population, 2024, Value in Health
  • EE465 Modeling the Effects of Improving Varicella Vaccination Coverage Rates on Clinical and Economic Outcomes in Peru Over a 10-Year Time-Horizon, 2024, Value in Health
  • EE832 The Lifetime Return on Investment of Measles, Mumps, and Rubella Vaccination in Belgium and Poland, 2024, Value in Health

Jean Lang frequently collaborates with several co-authors. The most recurrent collaborators include Manjiri Pawaskar, with three joint publications, followed by Colleen Burgess with two, and others such as Charles E. McGee, Konstantin A. Tsetsarkin, and Bruno Guy contributing to single co-authored works.

Jean Lang's research engages with modeling clinical and economic outcomes related to vaccination programs, with a focus on varicella, herpes zoster, and the measles, mumps, and rubella (MMR) vaccine. Their work addresses both the epidemiological impacts and the broader health economic returns of improved vaccination coverage over extended time horizons.

Best Publications

  • Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

    Arunee Sabchareon;Derek Wallace;Chukiat Sirivichayakul;Kriengsak Limkittikul

  • From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

    Bruno Guy;Beatrice Barrere;Claire Malinowski;Melanie Saville

  • Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

    Bruno Guy;Farshad Guirakhoo;Veronique Barban;Stephen Higgs

  • Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

    F. Guirakhoo;K. Pugachev;Z. Zhang;G. Myers

  • Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

    Arunee Sabchareon;Jean Lang;Pornthep Chanthavanich;Sutee Yoksan

  • Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

    Farshad Guirakhoo;Scott Kitchener;Dennis Morrison;Remi Forrat

  • A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults.

    Dennis Morrison;Thomas J. Legg;Christopher W. Billings;Remi Forrat

  • Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.

    Arunee Sabchareon;Jean Lang;Pornthep Chanthavanich;Sutee Yoksan

  • Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.

    Bruno Guy;Nolwenn Nougarede;Sarah Begue;Violette Sanchez

  • Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward

    Bruno Guy;Olivier Briand;Jean Lang;Melanie Saville

  • Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.

    Rosario Z. Capeding;Imelda A. Luna;Emily Bomasang;Socorro Lupisan

  • Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

    Scott Kitchener;Michael Nissen;Peter Nasveld;Remi Forrat

  • Evaluation of interferences between dengue vaccine serotypes in a monkey model.

    Bruno Guy;Veronique Barban;Nathalie Mantel;Marion Aguirre

  • Development of Sanofi Pasteur tetravalent dengue vaccine.

    Bruno Guy;Melanie Saville;Jean Lang

  • Antibody Persistence Following Preexposure Regimens of Cell-Culture Rabies Vaccines: 10-Year Follow-Up and Proposal for a New Booster Policy

    Alain Strady;Jean Lang;Michel Lienard;Christine Blondeau

  • Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity.

    Jorge Poo;Francisco Galan;Remi Forrat;Betzana Zambrano

  • Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans.

    Ming Qiao;David Shaw;Remi Forrat;Anh Wartel-Tram

  • Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine

    Arunee Sabchareon;Pornthep Chantavanich;Sataporn Pasuralertsakul;Chanathep Pojjaroen-Anant

  • Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3).

    Violette Sanchez;Sophie Gimenez;Brian Tomlinson;Paul K.S. Chan

  • Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.

    J. Lang;P. Attanath;B. Quiambao;V. Singhasivanon

  • Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.

    Bruno Guy;Pornthep Chanthavanich;Sophie Gimenez;Chukiat Sirivichayakul

Frequent Co-Authors

Richard M. Kinney
Richard M. Kinney Centers for Disease Control and Prevention
Sutee Yoksan
Sutee Yoksan Mahidol University
Thomas P. Monath
Thomas P. Monath Crozet BioPharma
Stephen Higgs
Stephen Higgs Kansas State University
Michael D. Nissen
Michael D. Nissen University of Queensland
Derek A. T. Cummings
Derek A. T. Cummings University of Florida
Scott B. Halstead
Scott B. Halstead Uniformed Services University of the Health Sciences
Donald S. Burke
Donald S. Burke University of Pittsburgh
Stanley A. Plotkin
Stanley A. Plotkin University of Pennsylvania
Dana L. Vanlandingham
Dana L. Vanlandingham Kansas State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various allied health and nursing careers that complement this specialized field. Many students explore related pathways such as becoming a Licensed Practical Nurse (LPN) or advancing to a Nurse Practitioner role. For those just starting, the best easiest lpn programs to get into offer accessible entry points into the healthcare system with focused training and quicker completion times.

For individuals interested in advanced practice nursing, especially in mental health, selecting the right program is crucial. The easiest nurse practitioner degree programs provide flexible and approachable options to gain the necessary qualifications without sacrificing quality.

Psychiatric mental health nurse practitioners (PMHNPs) are in high demand, and choosing programs with strong clinical placement support is vital for hands-on experience. Resources like the pmhnp programs online with best clinical placement help students secure valuable practical training.

Cost is another important factor when pursuing online certifications in healthcare. Finding the cheapest pmhnp certificate programs can make this advanced education more accessible, allowing students to focus on building a rewarding career without excessive financial burden.

Best Scientists Citing Jean Lang

Trending Scientists

Recently Published Articles